C. Guillot, C. Guillonneau, P. Mathieu, C. A. Gerdes, S. Ménoret et al., Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection, J Immunol, vol.168, p.11823487, 2002.

C. Guillonneau, M. Hill, F. Hubert, E. Chiffoleau, C. Hervé et al., CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase, J Clin Invest, vol.117, pp.1096-1106, 2007.

E. Picarda, S. Bézie, V. Venturi, K. Echasserieau, E. Mérieau et al., MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection, J Clin Invest, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02167782

C. Guillonneau, E. Picarda, and I. Anegon, CD8+ regulatory T cells in solid organ transplantation, Curr Opin Organ Transplant, 2010.

X. L. Li, S. Ménoret, S. Bezie, L. Caron, D. Chabannes et al., Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance, J Immunol, vol.185, pp.823-833, 2010.

Q. Ning, Y. Sun, M. Han, L. Zhang, C. Zhu et al., Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection, J Immunol, vol.174, p.15905589, 2005.

A. Ghanekar, M. Mendicino, H. Liu, W. He, M. Liu et al., Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection, J Immunol, vol.172, p.15100314, 2004.

J. D. Fontenot, J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky, A function for interleukin 2 in Foxp3-expressing regulatory T cells, Nat Immunol, vol.6, pp.1142-1151, 2005.

I. Shalev, K. M. Wong, K. Foerster, Y. Zhu, C. Chan et al., The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis, Hepatology, vol.49, pp.387-397, 2009.

K. Foerster, A. Helmy, Y. Zhu, R. Khattar, O. A. Adeyi et al., The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection, J Hepatol, vol.53, p.20615566, 2010.

N. Joller, E. Lozano, P. R. Burkett, B. Patel, S. Xiao et al., Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses, Immunity, vol.40, p.24745333, 2014.

H. Liu, I. Shalev, J. Manuel, W. He, E. Leung et al., The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression, Eur J Immunol, vol.38, pp.3114-3126, 2008.

E. Picarda, I. Anegon, and C. Guillonneau, T-cell receptor specificity of CD8(+) Tregs in allotransplantation, Immunotherapy, vol.3, pp.35-37, 2011.

C. Mauri and M. R. Ehrenstein, The "short" history of regulatory B cells, Trends Immunol, vol.29, pp.34-40, 2008.

S. Manicassamy and B. Pulendran, Dendritic cell control of tolerogenic responses, Immunol Rev, vol.241, p.21488899, 2011.

S. Ménoret, A. Iscache, L. Tesson, S. Rémy, C. Usal et al., Characterization of immunoglobulin heavy chain knockout rats, Eur J Immunol, vol.40, p.21038471, 2010.

T. Anjubault, J. Martin, F. Hubert, C. Chauvin, D. Heymann et al., Constitutive expression of TNF-related activation-induced cytokine (TRANCE)/receptor activating NF-?B ligand (RANK)-L by rat plasmacytoid dendritic cells, PLoS ONE, vol.7, p.22428075, 2012.

A. Toromanoff, Y. Chérel, M. Guilbaud, M. Penaud-budloo, R. O. Snyder et al., Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle, Mol Ther, vol.16, pp.1291-1299, 2008.

L. Guiner, C. Stieger, K. Snyder, R. O. Rolling, F. Moullier et al., Immune responses to gene product of inducible promoters, Curr Gene Ther, vol.7, p.17979680, 2007.

M. Brüggemann, C. Teale, M. Clark, C. Bindon, and H. Waldmann, A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha, J Immunol, vol.142, p.2496159, 1989.

M. C. Cuturi, R. Josien, D. Cantarovich, L. Bugeon, I. Anegon et al., Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats, Eur J Immunol, vol.24, pp.1627-1631, 1994.

B. S. Schwartz, G. A. Levy, D. S. Fair, and T. S. Edgington, Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase, J Exp Med, vol.155, p.7200121, 1982.

C. Chan, M. Chan, M. Liu, L. Fung, E. H. Cole et al., Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity, J Immunol, vol.168, p.11994472, 2002.

M. Mendicino, M. Liu, A. Ghanekar, W. He, C. Koscik et al., Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts, Circulation, vol.112, pp.248-256, 2005.

P. A. Marsden, Q. Ning, L. S. Fung, X. Luo, Y. Chen et al., The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis, J Clin Invest, vol.112, pp.58-66, 2003.

M. C. Melnyk, I. Shalev, J. Zhang, A. Bartczak, R. M. Gorczynski et al., The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis, Scand J Rheumatol, vol.40, p.21469939, 2011.

C. Chan, L. S. Kay, R. G. Khadaroo, M. Chan, S. Lakatoo et al., Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells, J Immunol, vol.170, p.12682232, 2003.

I. Shalev, H. Liu, C. Koscik, A. Bartczak, M. Javadi et al., Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis, J Immunol, vol.180, p.18097026, 2008.

L. Xie, N. Ichimaru, M. Morita, J. Chen, P. Zhu et al., Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance, Liver Transpl, vol.18, pp.444-454, 2012.

T. L. Denning, S. W. Granger, S. Granger, D. Mucida, R. Graddy et al., Mouse TCRalphabeta +CD8alphaalpha intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses, J Immunol, vol.178, p.17371979, 2007.

W. W. Hancock, F. M. Szaba, K. N. Berggren, M. A. Parent, I. K. Mullarky et al., Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2, Proc Natl Acad Sci USA, vol.101, pp.3005-3010, 2004.

C. Mauri and A. Bosma, Immune regulatory function of B cells, Annu Rev Immunol, vol.30, p.22224776, 2012.

S. Deng, D. J. Moore, X. Huang, M. Lian, M. Mohiuddin et al., Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes, J Immunol, vol.178, p.17475825, 2007.
DOI : 10.4049/jimmunol.178.10.6028
URL : http://www.jimmunol.org/content/178/10/6028.full.pdf

K. M. Lee, J. I. Kim, R. Stott, J. Soohoo, M. R. O'connor et al., Anti-CD45RB/Anti-TIM-1-Induced Tolerance Requires Regulatory B Cells, Am J Transplant, vol.12, pp.2072-2078, 2012.

L. Texier, L. , T. P. Lavault, A. Usal, C. Merieau et al., Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile, Am J Transplant, vol.11, p.21114655, 2011.

K. A. Newell, A. Asare, A. D. Kirk, T. D. Gisler, K. Bourcier et al., Identification of a B cell signature associated with renal transplant tolerance in humans, J Clin Invest, vol.120, p.20501946, 2010.

P. Sagoo, E. Perucha, B. Sawitzki, S. Tomiuk, D. A. Stephens et al., Development of a crossplatform biomarker signature to detect renal transplant tolerance in humans, J Clin Invest, vol.120, pp.1848-1861, 2010.

A. R. Kendal and H. Waldmann, Infectious tolerance: therapeutic potential, Curr Opin Immunol, vol.22, p.20829013, 2010.

S. Qin, S. P. Cobbold, H. Pope, J. Elliott, D. Kioussis et al., Infectious" transplantation tolerance, Science, vol.259, p.8094901, 1993.

K. Yanaba, J. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto et al., A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses, Immunity, vol.28, pp.639-650, 2008.

P. Neves, V. Lampropoulou, E. Calderon-gomez, T. Roch, U. Stervbo et al., Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection, Immunity, vol.33, p.21093317, 2010.

A. Pallier, S. Hillion, R. Danger, M. Giral, M. Racapé et al., Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype, Kidney Int, vol.78, pp.503-513, 2010.

B. Wei, P. Velazquez, O. Turovskaya, K. Spricher, R. Aranda et al., Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets, Proc Natl Acad Sci USA, vol.102, pp.2010-2015, 2005.

P. A. Blair, K. A. Chavez-rueda, J. G. Evans, M. J. Shlomchik, A. Eddaoudi et al., Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice, J Immunol, vol.182, pp.3492-3502, 2009.

L. Qian, C. Qian, Y. Chen, Y. Bai, Y. Bao et al., Regulatory dendritic cells program B cells to differentiate into CD19hiFc?IIbhi regulatory B cells through IFN-? and CD40L, Blood, vol.120, pp.581-591, 2012.

M. Matsumoto, Y. Fujii, A. Baba, M. Hikida, T. Kurosaki et al., The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production, Immunity, vol.34, pp.703-714, 2011.

M. K. Mann, K. Maresz, L. P. Shriver, Y. Tan, and B. N. Dittel, B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis, J Immunol, vol.178, p.17339439, 2007.

N. A. Carter, R. Vasconcellos, E. C. Rosser, C. Tulone, A. Muñoz-suano et al., Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells, J Immunol, vol.186, p.21464089, 2011.

S. Amu, S. P. Saunders, M. Kronenberg, N. E. Mangan, A. Atzberger et al., Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model, J Allergy Clin Immunol, vol.125, p.20304473, 2010.